Lepi-Go Vitex Plus Capsule 500mg
Lepi-Go Vitex Plus Capsule 500mg : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Folium Ginkgo Biloba | Folium Ginkgo Biloba[120;mg;500;mg] | Not identified |
| Radix Angelica Sinensis Extract | Radix Angelica Sinensis Extract[12;mg;500;mg] | Not identified |
| Vitex agnus-castus | Vitex agnus-castus[20;mg;500;mg] | Not identified |
| Radix Lepidium Meyenii (Maca) | Radix Lepidium Meyenii (Maca)[341.5;mg;500;mg] | Not identified |
| cimifuga racemosa extract | cimifuga racemosa extract[6.5;mg;500;mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL17080007T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Manufacturer
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Registration period starting
- 2022-08-04
- Published validity end
- 2027-08-04
Original register data
View published fields and their variants
- Active ingredients
- Folium Ginkgo Biloba[120;mg;500;mg],Radix Angelica Sinensis Extract[12;mg;500;mg],Vitex agnus-castus[20;mg;500;mg],Radix Lepidium Meyenii (Maca)[341.5;mg;500;mg],cimifuga racemosa extract[6.5;mg;500;mg]
- Valid until
- 2027-08-04
- Registration date
- 2022-08-04
- Published description
- NATURAL PRODUCT
- Licence holder
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Producer
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Published name
- Lepi-Go Vitex Plus Capsule 500mg
- Published reference
- 2015042404489
- Registration number
- MAL17080007T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL17080007T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitex agnus-castus
Read the warning, when it applies and the studies cited
CHASTE TREE - VITEX AGNUS-CASTUS
Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).
Sources cited by Health Canada (4)
- Bradley PR, editor. 2006. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
- OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.
Contraindications
Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).
Sources cited by Health Canada (9)
- Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dugoua JJ, Seely D, Pern D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex Agnus-Castus) during pregnancy and lactation. Can J. Clin Pharmacol 2008;15(1);e74-e79.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Vitex agnus-castus L., fructus. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 27 March 2018. [Accessed 2024 February 29] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vitex-agnus-castus-l-fructus-revision-1_en.pdf
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy in collaboration with Thieme.
- Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
- Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J. Pharmacopuncture 2022;25(2):106-113. PubMed
- WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
- OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Lepi-Go Vitex Plus Capsule 500mg”, https://compoatlas.com/en/supplements/malaysia/MAL17080007T-lepi-go-vitex-plus-capsule-500mg, updated 27 October 2026.